About ITM2B amyloidosis
ITM2B amyloidosis is a rare disease catalogued by Orphanet (ORPHA:439254). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to ITM2B amyloidosis trials.
Search ClinicalTrials.gov for "ITM2B amyloidosis" or Orphanet code ORPHA:439254 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting ITM2B amyloidosis trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for ITM2B amyloidosis. Updated daily.